CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone64-7872-2300
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$35.22 million
Profitability
Miscellaneous
Employees576
Next Earnings Date11/13/2019 (Estimated)
OptionableOptionable
CannTrust (NYSE:CTST) Frequently Asked Questions
What is CannTrust's stock symbol?
CannTrust trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTST."
When is CannTrust's next earnings date?
What price target have analysts set for CTST?
8 equities research analysts have issued 12-month price objectives for CannTrust's shares. Their predictions range from C$2.00 to C$7.00. On average, they anticipate CannTrust's stock price to reach C$4.50 in the next twelve months. This suggests a possible upside of 448.8% from the stock's current price. View Analyst Price Targets for CannTrust.
What is the consensus analysts' recommendation for CannTrust?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CannTrust.
Has CannTrust been receiving favorable news coverage?
Media headlines about CTST stock have been trending negative this week, according to InfoTrie. The research group ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CannTrust earned a daily sentiment score of -2.6 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for CannTrust.
Are investors shorting CannTrust?
CannTrust saw a increase in short interest in September. As of September 15th, there was short interest totalling 12,990,000 shares, an increase of 6.3% from the August 15th total of 12,220,000 shares. Based on an average trading volume of 4,290,000 shares, the short-interest ratio is presently 3.0 days. Currently, 14.7% of the company's shares are sold short. View CannTrust's Current Options Chain.
Who are some of CannTrust's key competitors?
Some companies that are related to CannTrust include IGM Biosciences (IGMS), Basilea Pharmaceutica (BPMUF), Flexion Therapeutics (FLXN), Catalyst Pharmaceuticals (CPRX), TG Therapeutics (TGTX), Aptorum Group (APM), Akorn (AKRX), Retrophin (RTRX), Viking Therapeutics (VKTX), Sinovac Biotech (SVA), Lannett (LCI), Urogen Pharma (URGN), Progenics Pharmaceuticals (PGNX), INDIVIOR PLC/S (INVVY) and ChemoCentryx (CCXI).
What other stocks do shareholders of CannTrust own?
Who are CannTrust's key executives?
CannTrust's management team includes the folowing people:
- Mr. Eric Paul, Co-Founder & Chairman (Age 78)
- Mr. Brad Rogers, Pres (Age 49)
- Mr. Ian Abramowitz, Sr. VP of Global Investments & Partnerships (Age 64)
- Mr. Peter Ralph Aceto, Chief Exec. Officer
- Mr. Greg Guyatt, Chief Financial Officer
Who are CannTrust's major shareholders?
CannTrust's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Legacy Advisors LLC (0.04%). Company insiders that own CannTrust stock include Aubrey Dan, Financial Corporation Forum, Mark Litwin and Mitchell J Sanders. View Institutional Ownership Trends for CannTrust.
Which institutional investors are selling CannTrust stock?
How do I buy shares of CannTrust?
Shares of CTST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is CannTrust's stock price today?
One share of CTST stock can currently be purchased for approximately C$0.82.
How big of a company is CannTrust?
CannTrust has a market capitalization of C$116.01 million and generates C$35.22 million in revenue each year. The company earns C$-10,460,000.00 in net income (profit) each year or C($0.11) on an earnings per share basis. CannTrust employs 576 workers across the globe.View Additional Information About CannTrust.
What is CannTrust's official website?
How can I contact CannTrust?
CannTrust's mailing address is 3280 LANGSTAFF ROAD UNIT 1, VAUGHAN A6, L4K 4Z8. The company can be reached via phone at 64-7872-2300 or via email at [email protected]
MarketBeat Community Rating for CannTrust (NYSE CTST)
MarketBeat's community ratings are surveys of what our community members think about CannTrust and other stocks. Vote "Outperform" if you believe CTST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTST will underperform the S&P 500 over the long term. You may vote once every thirty days.
